A Recombinant Human Glucagon-Like Peptide (GLP)-1–Albumin Protein (Albugon) Mimics Peptidergic Activation of GLP-1 Receptor–Dependent Pathways Coupled With Satiety, Gastrointestinal Motility, and Glucose Homeostasis - Baggio, Laurie L.; Huang, Qingling; Brown, Theodore J.; Drucker, Daniel J. (Diabetes (New York, N.Y.), 2004)
Keywords: Albumins - genetics; Albumins - pharmacology; Animals; Biological and medical sciences; Cells, Cultured; Cricetinae; Diabetes; Diabetes. Impaired glucose tolerance; Eating - drug effects; Eating - physiology; Endocrine pancreas. Apud cells (diseases); Endocrinopathies; Energy consumption; Food; Gastric Emptying - drug effects; Gastric Emptying - physiology; Gastrointestinal Motility - drug effects; Gastrointestinal Motility - physiology; Glucagon; Glucagon - genetics; Glucagon - pharmacology; Glucagon-Like Peptide 1; Glucagon-Like Peptide-1 Receptor; Glucose; Glucose - metabolism; Homeostasis; Homeostasis - drug effects; Homeostasis - physiology; Human subjects; Humans; Insulin; Kidney - cytology; Medical sciences; Mice; Mice, Inbred C57BL; Mice, Mutant Strains; Motility; Peptide Fragments - genetics; Peptide Fragments - pharmacology; Peptides; Plasma; Protein Precursors - genetics; Protein Precursors - pharmacology; Proteins; Proto-Oncogene Proteins c-fos - metabolism; Rats; Receptors, Glucagon - genetics; Receptors, Glucagon - metabolism; Recombinant Proteins - pharmacology; Satiety Response - drug effects; Satiety Response - physiology; Endocrinopathy; Human; Motility; Diabetes mellitus; Albumin; Homeostasis; Satiety; Glucose; Gastrointestinal; Protein; Biological receptor